Statistical treatment of withdrawal in trials of anti-dementia drugs - Reply

被引：1

作者：

Doody, Rachelle ^{[1
]}

Seely, Lynn ^{[2
]}

Thomas, Ronald ^{[3
]}

Sano, Mary ^{[4
]}

Aisen, Paul ^{[5
]}

机构：

[1] Baylor Coll Med, Alzheimers Dis & Memory Disorders Ctr, Dept Neurol, Houston, TX 77030 USA

[2] Medivation Inc, San Francisco, CA USA

[3] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA

[4] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY USA

[5] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA

来源：

LANCET | 2008年 / 372卷 / 9647期

关键词：

D O I：

10.1016/S0140-6736(08)61582-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1383 / 1383

页数：1

共 6 条

[1]

[Anonymous], 1998, Int J Geriatr Psychopharmacol

[2] Galantamine in AD - A 6-month randomized, placebo-controlled trial with a 6-month extension [J].

Raskind, MA ;

Peskind, ER ;

Wessel, T ;

Yuan, W .

NEUROLOGY, 2000, 54 (12) :2261-2268

[3] Memantine in moderate-to-severe Alzheimer's disease [J].

Reisberg, B ;

Doody, R ;

Stoffler, A ;

Schmitt, F ;

Ferris, S ;

Mobius, HJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1333-1341

[4] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease [J].

Rogers, SL ;

Farlow, MR ;

Doody, RS ;

Mohs, R ;

Friedhoff, LT ;

Albala, B ;

Baumel, B ;

Booker, G ;

Dexter, J ;

Farmer, M ;

Feighner, JP ;

Ferris, S ;

Gordon, B ;

Gorman, DG ;

Hanna, G ;

Harrell, LE ;

Hubbard, R ;

Kennedy, J ;

McCarthy, J ;

Scharre, DW ;

Schaerf, F ;

Schneider, L ;

Seltzer, B ;

Siegal, A ;

Stark, SR ;

Strauss, A ;

Walshe, TM .

NEUROLOGY, 1998, 50 (01) :136-145

[5]

Thomas RG, 2000, STAT MED, V19, P1433, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1433::AID-SIM435>3.0.CO

[6]

2-F

← 1 →